Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2485872 | Journal of Pharmaceutical Sciences | 2007 | 15 Pages |
Abstract
Glycation of a recombinant monoclonal IgG2 molecule, in sucrose containing liquid formulations, was studied using reversedâphase LC/MS analysis of the intact IgG, the F(abâ²)2 fragments and after complete tryptic digestion. The extent of glycation in sucrose containing formulations was monitored at different temperatures over a period of 21 months using the Hexose index (HexI). HexI represents the average number of hexose molecules per molecule of IgG and was calculated by using the intensity values of peaks corresponding to hexose isoforms in the deconvoluted mass spectra. The rate of glycation in mildly acidic sucrose containing formulations was proportional to the incubation temperature. No glycation was observed in sucrose containing formulations incubated at 4°C even after 18 months. However, when the same formulations were incubated at 37°C glycation was observed after just 1 month. The glycation sites were mapped to 10 lysine residues distributed throughout the molecule. The amino terminal end of the light chain was also shown to contain glycation. The surface accessibility of the lysine side chain could influence its susceptibility to glycationand the American Pharmacists Association J Pharm Sci 96: 2607-2621, 2007
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Himanshu S. Gadgil, Pavel V. Bondarenko, Gary Pipes, Doug Rehder, Arnold McAuley, Natalie Perico, Tom Dillon, Margaret Ricci, Michael Treuheit,